Latest Tanabe Research Laboratories Stories
SAN DIEGO, Dec. 13, 2010 /PRNewswire/ -- Tanabe Research Laboratories U.S.A. Inc., (TRL) announced today that it has entered into a partnership with Anaphore Inc. for the research and preclinical development of novel protein therapies for autoimmune diseases based on Anaphore's proprietary Atrimer(TM) technology. TRL and Anaphore will generate novel trivalent proteins called Atrimers that can be programmed to bind to and activate or inhibit targets of interest. The partnership will focus...
- To talk saucily.
- Insolent, opprobrious language; impertinent abuse.